Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L35a pseudogene 19 (RPL35AP19) is a human pseudogene related to the functional RPL35A gene, which encodes a component of the large (60S) ribosomal subunit. RPL35AP19 is considered a processed pseudogene and does not encode a functional protein product. Unlike the functional RPL35A gene, which is essential for ribosome function and has been linked to disorders such as Diamond-Blackfan anemia, RPL35AP19 has no known biological function, no recognized role in disease, and is not considered a drug target or biomarker. It is annotated as a distinct, non-coding locus in the human genome.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L35a pseudogene 19 (RPL35AP19).